Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06532123 · ClinicalTrials.gov registry record · NA
Mechanisms of Improving Fecal Continence Muscles Motor Function
A NA study of Fecal Incontinence, sponsored by Medical College of Wisconsin.
- Recruiting
- Registry status
- NA
- Development phase
- 340
- Enrollment target
- 1
- Study location
NCT06532123: Recruiting NA study of Fecal Incontinence, sponsored by Medical College of Wisconsin.
NCT06532123 is a NA study of Fecal Incontinence that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 340 participants, roughly in line with the 320-participant average among 22 other Fecal Incontinence trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06532123, a NA study of Fecal Incontinence, is actively recruiting participants, sponsored by Medical College of Wisconsin.
- RECRUITING
- Registry status
- NA
- Development phase
- 340 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators hypothesize that different continence muscles have different fatigue characteristics and fatigue induced by resisted contractions will result in significant increase in contractility of the continence muscles and improvement of fecal incontinence severity.
Primary Outcome
Maximum squeeze pressure, mean squeeze pressure and anal squeeze contractile integral
Conditions Studied
Interventions
- DEVICE continence muscles resistance device
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 340 participants |
| Start Date | 2025-07-15 |
| Est. Completion | 2030-03-01 |
| Phase | NA |
What NCT06532123 shows while recruiting
NCT06532123 is an interventional study that assigns participants to a tested intervention. The registered 340 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 320-participant average among 22 other Fecal Incontinence trials with a reported enrollment target.
The record links to 1 condition, with Fecal Incontinence appearing as the primary indexed condition, and to 1 intervention - of which continence muscles resistance device is the first listed.
NCT06532123 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT06532123 about?
NCT06532123 is a clinical study titled "Mechanisms of Improving Fecal Continence Muscles Motor Function". The investigators hypothesize that different continence muscles have different fatigue characteristics and fatigue induced by resisted contractions will result in significant increase in contractility of the continence muscles and improvement of fecal incontinence severity.
What is the current status of trial NCT06532123?
This trial is currently recruiting. It is a NA study. The enrollment target is 340 participants. The study started on 2025-07-15. Estimated completion is 2030-03-01.
What conditions does trial NCT06532123 study?
This clinical trial studies the following conditions: Fecal Incontinence.
What interventions are being tested in trial NCT06532123?
The interventions under investigation include: continence muscles resistance device (DEVICE).
Who is sponsoring clinical trial NCT06532123?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06532123 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fecal Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06532123's enrollment target sits among peer trials
340 2nd of 22 the highest of 22 other Fecal Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fecal Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Trial to Evaluate Fecobionics in Fecal Incontinence (FI) (NORMAL and ABNORMAL-FI)
RECRUITING · NA
-
Autologous Muscle Fiber Fragment Injections
RECRUITING · NA
-
Pelvic Health Electrically Evoked Recording (PEER) 2 Study
RECRUITING · NA
-
Home Biofeedback Therapy for Dyssynergic Defecation, Fecal Incontinence and Urinary Incontinence
RECRUITING · NA
-
Acute Genital Nerve Stimulation for Neurogenic Bowel Dysfunction in Individuals Living With Spinal Cord Injury
RECRUITING · NA
-
Fecal Incontinence Treatment (FIT) Study
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04176172 · 340 participants · Phase 3
Optimizing Tobacco Use Treatment for PLWHA
- NCT04545424 · 340 participants · Phase 2
Trial of Therapeutic Hypothermia in Patients With ARDS
- NCT04806958 · 340 participants · NA
The PulsePoint Study
- NCT05323409 · 340 participants · NA
Improving Comprehensive Care of Cancer Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI